SearchDictionaryMobileLogin

Nicholas J Vogelzang Selected Research

Hormones

02/2008Second-line Chemotherapy for Advanced Hormone-refractory Prostate Cancer.
07/2007Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid.
07/2006Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies.
03/2006Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
03/2006A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
08/2005Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study.
05/2005A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer.
04/2005Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer.
03/2005The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.
11/2004Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480.
08/2004Impact of race on survival in men with metastatic hormone-refractory prostate cancer.
05/2004A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.
02/2004Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer.
01/2004A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
12/2003A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.
04/2003Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.
02/2003Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial.
04/2002Importance of serum hemoglobin in hormone refractory prostate cancer.
02/2002Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B study.

Articles by Research Topic

Disease

26Prostatic Neoplasms (Prostate Cancer)
05/2008 - 04/2002
24Neoplasms (Cancer)
04/2008 - 01/2002
13Leukemia
04/2008 - 02/2002
8Mesothelioma
05/2008 - 01/2002
7Carcinoma (Carcinomatosis)
01/2007 - 02/2002
6Renal Cell Carcinoma (Grawitz Tumor)
02/2007 - 05/2002
3Kidney Neoplasms (Kidney Cancer)
07/2008 - 06/2003
2Urinary Bladder Neoplasms (Bladder Cancer)
09/2006 - 08/2003
1Pain (Aches)
05/2008
1Anoxia (Hypoxia)
03/2008
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2007
1Neoplasm Metastasis (Metastasis)
03/2006
1Venous Thromboembolism
10/2002
1Urogenital Neoplasms
02/2002

Drug/Important Bio-Agent (IBA)

19HormonesIBA
02/2008 - 02/2002
9gemcitabineFDA Link
09/2006 - 01/2002
5Fluorouracil (Carac)FDA LinkGeneric
01/2007 - 05/2002
4Cisplatin (Platino)FDA LinkGeneric
09/2006 - 07/2003
4Suramin (Suramin Sodium)IBA
11/2004 - 07/2002
3Ketoconazole (Nizoral)FDA LinkGeneric
11/2007 - 03/2004
3Interleukin-2 (IL2)IBA
03/2006 - 05/2002
3docetaxel (Taxotere)FDA Link
05/2005 - 12/2003
2Leucovorin (Folinic Acid)FDA LinkGeneric
01/2007 - 03/2006
2ranpirnase (Pannon)IBA
04/2006 - 01/2002
2flt3 ligand protein (flt3 ligand)IBA
02/2004 - 05/2002
2pemetrexed (MTA)FDA Link
07/2003 - 06/2003
2atrasentanIBA
03/2003 - 02/2003
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2008
15,6-dihydro-5-azacytidineIBA
04/2008
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
03/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2008
1Etoposide (VP 16)FDA LinkGeneric
11/2007
1zoledronic acid (zoledronate)FDA Link
07/2007
1sunitinib (Sutent)FDA Link
02/2007
1TP protocolIBA
01/2007
1Ribonucleases (Ribonuclease)IBA
04/2006
1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-ValinamideIBA
03/2006
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
03/2006
1nilutamide (Nilandron)FDA Link
10/2005
1Flutamide (Eulexin)FDA LinkGeneric
10/2005
1bicalutamide (Casodex)FDA Link
10/2005
1Chromogranin AIBA
08/2005
1sulindac sulfone (exisulind)IBA
05/2005
1Methotrexate (Mexate)FDA LinkGeneric
04/2005
1Interleukin-6 (Interleukin 6)IBA
03/2005
1tyrosine receptor (receptor, tyrosine)IBA
11/2004
1CEP 2563IBA
11/2004
1Phosphotransferases (Kinase)IBA
11/2004
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
08/2004
1Epidermal Growth Factor (EGF)IBA
08/2004
1SU 5416 (SU5416)IBA
05/2004
1Estradiol (Estrace)FDA LinkGeneric
01/2004
1alpha-methylacyl-CoA racemaseIBA
01/2004
1bortezomib (Velcade)FDA Link
01/2004
1EstramustineFDA Link
12/2003
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2003
1Carboplatin (JM8)FDA LinkGeneric
12/2003
1Androgen Receptors (Androgen Receptor)IBA
07/2003
1oxaliplatin (Eloxatin)FDA Link
07/2003
1Paclitaxel (Taxol)FDA LinkGeneric
06/2003
1Endothelin Receptors (Endothelin Receptor)IBA
03/2003
1Endothelin A ReceptorIBA
02/2003
1Thalidomide (Thalomid)FDA Link
10/2002
1Interferon-alpha (Interferon Alfa)FDA Link
05/2002
1Hemoglobins (Hemoglobin)IBA
04/2002
1Folic Acid AntagonistsIBA
02/2002
1Mitoxantrone (Novantrone)FDA LinkGeneric
02/2002
1capecitabine (Xeloda)FDA Link
01/2002

Therapy/Procedure

8Drug Therapy (Chemotherapy)
05/2008 - 04/2002
4Castration
05/2008 - 11/2005
2Stem Cell Transplantation
01/2003 - 04/2002
1Prostatectomy (Retropubic Prostatectomy)
02/2007
1Immunotherapy
02/2004
1Nephrectomy
02/2004
1Cystectomy
08/2003